Oncolytics Biotech
ONCY
#9159
Rank
A$0.17 B
Marketcap
A$1.53
Share price
-5.22%
Change (1 day)
71.71%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -A$38.66 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$35.68 Million a decrease over its 2023 earnings that were of -A$35.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.66 Million8.35%
2024 -A$35.68 Million1.01%
2023 -A$35.33 Million23.39%
2022 -A$28.63 Million-1.98%
2021 -A$29.21 Million9.1%
2020 -A$26.77 Million22.64%
2019 -A$21.83 Million22.78%
2018 -A$17.78 Million4.1%
2017 -A$17.08 Million4.87%
2016 -A$16.29 Million8.75%
2015 -A$14.98 Million-37.06%
2014 -A$23.79 Million-26.2%
2013 -A$32.24 Million-37.39%
2012 -A$51.49 Million28.8%
2011 -A$39.98 Million46.02%
2010 -A$27.38 Million35.64%
2009 -A$20.19 Million-14.2%
2008 -A$23.53 Million-0.52%
2007 -A$23.65 Million24.6%
2006 -A$18.98 Million45.34%
2005 -A$13.06 Million-11.8%
2004 -A$14.81 Million115.36%
2003 -A$6.88 Million13.86%
2002 -A$6.04 Million-5.45%
2001 -A$6.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$36.08 B-103,533.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.08 B-37,596.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.08 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.7 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.01 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$40.72 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA